Carson Wealth (CWM LLC)’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,432
| Closed | -$17K | – | 5268 |
|
|
2024
Q4 | $17K | Sell |
5,432
-3,262
| -38% | -$10.2K | ﹤0.01% | 3560 |
|
|
2024
Q3 | $45K | Buy |
8,694
+7,304
| +525% | +$37.8K | ﹤0.01% | 2774 |
|
|
2024
Q2 | $4K | Buy |
1,390
+541
| +64% | +$1.56K | ﹤0.01% | 4020 |
|
|
2024
Q1 | $4K | Buy |
849
+653
| +333% | +$3.08K | ﹤0.01% | 3806 |
|
|
2023
Q4 | $2K | Buy |
196
+151
| +336% | +$1.54K | ﹤0.01% | 3861 |
|
|
2023
Q3 | $1K | Sell |
45
-128
| -74% | -$2.84K | ﹤0.01% | 4110 |
|
|
2023
Q2 | $4K | Sell |
173
-12
| -6% | -$277 | ﹤0.01% | 3576 |
|
|
2023
Q1 | $6K | Sell |
185
-7
| -4% | -$227 | ﹤0.01% | 3246 |
|
|
2022
Q4 | $4K | Buy |
192
+36
| +23% | +$750 | ﹤0.01% | 3349 |
|
|
2022
Q3 | $4K | Hold |
156
| – | – | ﹤0.01% | 3236 |
|
|
2022
Q2 | $2K | Buy |
156
+32
| +26% | +$410 | ﹤0.01% | 3434 |
|
|
2022
Q1 | $2K | Buy |
124
+91
| +276% | +$1.47K | ﹤0.01% | 3246 |
|
|
2021
Q4 | $1K | Buy |
+33
| New | +$1K | ﹤0.01% | 3392 |
|